Price Transparency Slowdown May Aid Strategic Response

Delays are hitting some aspects of the federal price transparency agenda — the complex web of laws, rules and regulations targeting insurers, providers and pharmacy stakeholders, among others. But policy experts say it’s not time to sit back and wait.

That’s what a panel of payer- and provider-focused insiders from the Advisory Board recommended during a Dec. 1 webinar covering federal transparency requirements for the health care sector.

0 Comments
© 2022 MMIT
Freelance Reporter

Freelance Reporter Freelance Reporter

Related Posts

molina-logo-on-phone
July 1

Behavioral Health Network Issues Lead to $4.6M Fine for Molina

READ MORE
woman-using-phone
July 1

Plan Sponsors, Insurers Scramble to Adapt to Abortion Bans

READ MORE
a-patient-taking-pills
July 1

Fewer Abortion Facilities Accept Health Insurance, While Patients Face Higher Out-of-Pocket Expenses for Abortion

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today